Most automakers’ Q2 sales in the U.S. didn’t fare well, and of the three that did experience gains, one stood out ...

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...

Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see ...

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

Relive automotive history! Join us as we drive all 5 generations of the iconic Honda Prelude just before the exciting new ...

General Motors' Hummer EV and Ford's F-150 Lightning beat Tesla's Cybertruck in the US electric pick-up market for Q2 2025.

A total of 310,839 new electric cars were sold in the US in the second quarter, according to data from Kelley Blue Book.

The GMC Hummer EV outperformed Tesla's Cybertruck in the second quarter of 2025, with sales figures revealing a significant drop in Cybertruck purchases.